Showing results (1101-1110 of 1,519) with videos related to
Sort By:
Pageof 152
Familial Cancer|May 5, 2025
Evaluation of BRCA1/2 testing rates in epithelial ovarian cancer patients: lessons learned from real-world clinical dataLieke Lanjouw, Claire J H Kramer, Arja Ter Elst, et al.Familial Cancer|May 3, 2025
A series of reviews in familial cancer: genetic cancer risk in context variants of uncertain significance in MMR genes: which procedures should be followed?Morghan C Lucas, Thomas Keßler, Florentine Scharf, et al.Familial Cancer|March 30, 2025
The patterns and spectrum of BRCA1 and BRCA2 mutations in Iranian breast and ovarian cancer patientsShayan Forghani, Hamid Reza Mirzaee, Hamid Rezvani, et al.Familial Cancer|April 12, 2025
One hundred years of the St Mark's hospital polyposis registryVicky Cuthill, Andy Latchford, Sue ClarkFamilial Cancer|April 10, 2025
Causes of DNA mismatch repair deficiency in sebaceous skin lesions demonstrating loss of MLH1 protein expression: constitutional over somatic MLH1 promoter methylationJihoon E Joo, Khalid Mahmood, Mark Clendenning, et al.Familial Cancer|March 18, 2025
Non-serous ovarian cancer in PTEN Hamartoma Tumor Syndrome: additional evidence for increased riskAne J Schei-Andersen, Vera M Witjes, Janet R Vos, et al.Familial Cancer|June 7, 2024
Detection of a major Lynch Syndrome-causing MLH1 founder variant in a large-scale genotyped cohortLauri J Sipilä, Mervi Aavikko, Janne Ravantti, et al.Familial Cancer|July 20, 2024
Report of the sixth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Paris, France, November 16th 2022Léa Guerrini-Rousseau, Richard Gallon, Marta Pineda, et al.Familial Cancer|May 19, 2024
A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysisAdrien Mouren, Albain Chansavang, Nadim Hamzaoui, et al.Familial Cancer|May 15, 2024
Cascade genetic testing: an underutilized pathway to equitable cancer care?Roni Nitecki Wilke, Erica M Bednar, Sara Pirzadeh-Miller, et al.Pageof 152